Open Access

Platyconic acid A‑induced PPM1A upregulation inhibits the proliferation, inflammation and extracellular matrix deposition of TGF‑β1‑induced lung fibroblasts

  • Authors:
    • Chengcheng Su
    • Yanfen Tang
    • Cong Wang
    • Haifeng Huang
    • Haihui Hou
  • View Affiliations

  • Published online on: September 6, 2022     https://doi.org/10.3892/mmr.2022.12845
  • Article Number: 329
  • Copyright: © Su et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Platyconic acid A (PA), the active component of Platycodi radix‑derived saponin, exerts ameliorating effects on liver fibrosis. Platycodon grandiflorum is used to treat lung disease. Therefore, the present study evaluated the effects of PA on pulmonary fibrosis. Transforming growth factor‑β1 (TGF‑β1) was used to induce MRC‑5 cells to establish an in vitro pulmonary fibrosis model. The viability of MRC‑5 cells in the presence or absence of TGF‑β1 induction was examined using a Cell Counting Kit‑8 assay and the results demonstrated that PA markedly decreased viability of TGF‑β1‑induced MRC‑5 cells in a dose‑dependent manner. Wound healing analysis, immunofluorescent staining and western blotting were performed to determine the levels of cell migration and expression of α‑smooth muscle actin and extracellular matrix (ECM)‑associated proteins. The results of the present study demonstrated that PA significantly suppressed the migration and ECM deposition of TGF‑β1‑induced MRC‑5 cells. Furthermore, results obtained from ELISA and western blotting demonstrated that PA exerted suppressive effects on the inflammation of MRC‑5 cells following TGF‑β1 stimulation. The mRNA and protein expression levels of protein phosphatase Mg2+/Mn2+‑dependent 1A (PPM1A) before and after transfection were assessed using reverse transcription‑quantitative PCR and western blotting and the results demonstrated that the mRNA and protein expression levels of PPM1A were significantly decreased following transfection with small interfering RNA targeting PPM1A. Moreover, following PPM1A knockdown, PA significantly inhibited the proliferation, migration, inflammation and ECM deposition of TGF‑β1‑induced MRC‑5 cells via activation of the SMAD/β‑catenin signaling pathway. In conclusion, PA activated PPM1A to ameliorate TGF‑β1‑elicited lung fibroblast injury via modulating SMAD/β‑catenin signaling.
View Figures
View References

Related Articles

Journal Cover

November-2022
Volume 26 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Su C, Tang Y, Wang C, Huang H and Hou H: Platyconic acid A‑induced PPM1A upregulation inhibits the proliferation, inflammation and extracellular matrix deposition of TGF‑β1‑induced lung fibroblasts. Mol Med Rep 26: 329, 2022
APA
Su, C., Tang, Y., Wang, C., Huang, H., & Hou, H. (2022). Platyconic acid A‑induced PPM1A upregulation inhibits the proliferation, inflammation and extracellular matrix deposition of TGF‑β1‑induced lung fibroblasts. Molecular Medicine Reports, 26, 329. https://doi.org/10.3892/mmr.2022.12845
MLA
Su, C., Tang, Y., Wang, C., Huang, H., Hou, H."Platyconic acid A‑induced PPM1A upregulation inhibits the proliferation, inflammation and extracellular matrix deposition of TGF‑β1‑induced lung fibroblasts". Molecular Medicine Reports 26.5 (2022): 329.
Chicago
Su, C., Tang, Y., Wang, C., Huang, H., Hou, H."Platyconic acid A‑induced PPM1A upregulation inhibits the proliferation, inflammation and extracellular matrix deposition of TGF‑β1‑induced lung fibroblasts". Molecular Medicine Reports 26, no. 5 (2022): 329. https://doi.org/10.3892/mmr.2022.12845